Transcriptional deregulation of <i>LSD1</i> and <i>LSD2</i> is associated with cytogenetic risk in chronic lymphocytic leukemia-Reference-Cited by-同舟云学术

Transcriptional deregulation of LSD1 and LSD2 is associated with cytogenetic risk in chronic lymphocytic leukemia

Published:2022-08-25 Issue:13 Volume:63 Page:3227-3231
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Costa Daniel Freitas da¹²,Filiú-Braga Luma Dayane de Carvalho¹,Silva-Carvalho Amandda Évelin¹,Schiavinato Josiane Lilian³,Vasconcelos Maria Catarina Cals de⁴,Figueiredo-Pontes Lorena Lôbo de³,Lucena-Araujo Antonio Roberto⁵,Saldanha-Araujo Felipe¹²^ORCID

Affiliation:

1. Laboratório de Hematologia e Células-Tronco, Universidade de Brasília, Brasilia, Brasil

2. Laboratório de Farmacologia Molecular, Universidade de Brasília, Brasilia, Brasil

3. Laboratório de Hematologia, Universidade de São Paulo, São Paulo, Brazil

4. Hospital de Base do Distrito Federal, Setor Hospitalar Sul, Brasília, Brazil

5. Laboratório de Hematologia, Universidade Federal de Pernambuco, Recife, Brazil

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2022.2116935

Reference17 articles.

1. Cytogenetics in Chronic Lymphocytic Leukemia: ERIC Perspectives and Recommendations

2. Complex karyotype is a stronger predictor than del(17p) for an inferior outcome in relapsed or refractory chronic lymphocytic leukemia patients treated with ibrutinib-based regimens

3. Biological roles of LSD1 beyond its demethylase activity

4. LSD1/KDM1A inhibitors in clinical trials: advances and prospects

5. BloodSpot: a database of gene expression profiles and transcriptional programs for healthy and malignant haematopoiesis